Produced by the Royal College of Physicians of Edinburgh and Royal College of Physicians and Surgeons of Glasgow

References

  1. Scottish Intercollegiate Guidelines Network (SIGN). SIGN 69: Management of obesity in childeren and young people. Edinburgh: SIGN; 2003.
  2. Food Dudes Programme
  3. Sign Intercollegiate Guidelines Network (SIGN). Sign 8: Obesity in Scotland: integrating prevention with weight management. Edinburgh: SIGN; 1996.
  4. Clegg AJ, Colquitt J, Sidhu MK et al. The clinical effectiveness and cost-effectiveness of surgery for people with morbid obesity: a systematic review and economic evaluation. Health Technol Assess 2002; 6(12):1-153.
  5. Avenell A, Broom J, Brown TJ et al. Systematic review of the long term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess. Due to be published early 2004.
  6. US Preventive Services Task Force. Screening for obesity in adults. 2003.
  7. Hansson L, Zanchetti A, Carruthers SG et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998; 351(9118):1755-62.
  8. Blaufox MD, Langford HG, Oberman A et al. Effect of dietary change on the return of hypertension after withdrawal of prolonged antihypertensive therapy (DISH). Dietary Intervention Study of Hypertension. J Hypertens Suppl 1984; 2(3):S179-81.
  9. Foster GD, Wyatt HR, Hill JO et al. A randomised trial of a low carbohydrate diet for obesity (Atkins) New Engl J Med 2003; 348:2082-90.
  10. Batey DM, Kaufmann PG, Raczynski JM et al. Stress management intervention for primary prevention of hypertension: detailed results from Phase I of Trials of Hypertension Prevention (TOHP-I). Ann Epidemiol 2000; 10(1):45-58.
  11. Stevens VJ, Obarzanek E, Cook NR et al. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II. Ann Intern Med 2001; 134(1):1-11.
  12. Kubaszek A, Pihlajamaki J, Komarovski V et al. Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study. Diabetes 2003; 52(7):1872-6.
  13. Torgerson JS, Hauptman J, Boldrin MN et al. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004; 27(1):155-61.
  14. Clarke P, Gray A, Adler A et al. Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51). Diabetologia 2001; 44(3):298-304.
  15. Diabetes Prevention Program Research Group: reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346:393-403.
  16. Full guidance on the use of surgery to aid weight reduction for people with morbid obesity.